Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112226937 | 11222693 | 7 | F | 201401 | 20160811 | 20150626 | 20160817 | EXP | PHHY2013CA153093 | NOVARTIS | 72.03 | YR | M | Y | 0.00000 | 20160817 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112226937 | 11222693 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 112226937 | 11222693 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 112226937 | 11222693 | 3 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 112226937 | 11222693 | 4 | C | EPIPEN | EPINEPHRINE | 1 | Unknown | U | 0 | ||||||||||
| 112226937 | 11222693 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 40 MG, BID | Y | 0 | 40 | MG | BID | ||||||
| 112226937 | 11222693 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 112226937 | 11222693 | 7 | C | SLOW K | POTASSIUM CHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 112226937 | 11222693 | 8 | C | CHOLESTROL | 2 | Unknown | U | 0 | PILL (EXCEPT TABLETS) |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112226937 | 11222693 | 1 | Chronic myeloid leukaemia |
| 112226937 | 11222693 | 3 | Product used for unknown indication |
| 112226937 | 11222693 | 4 | Product used for unknown indication |
| 112226937 | 11222693 | 5 | Product used for unknown indication |
| 112226937 | 11222693 | 7 | Product used for unknown indication |
| 112226937 | 11222693 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112226937 | 11222693 | OT |
| 112226937 | 11222693 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112226937 | 11222693 | Asthenia | |
| 112226937 | 11222693 | Concomitant disease aggravated | |
| 112226937 | 11222693 | Dyspnoea | |
| 112226937 | 11222693 | Fatigue | |
| 112226937 | 11222693 | Feeling abnormal | |
| 112226937 | 11222693 | Heart valve incompetence | |
| 112226937 | 11222693 | Hypersensitivity | |
| 112226937 | 11222693 | Insomnia | |
| 112226937 | 11222693 | Myocardial infarction | |
| 112226937 | 11222693 | Pain in extremity | |
| 112226937 | 11222693 | Periorbital oedema | |
| 112226937 | 11222693 | Peripheral swelling | |
| 112226937 | 11222693 | Pleural effusion | |
| 112226937 | 11222693 | Swelling face | |
| 112226937 | 11222693 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112226937 | 11222693 | 1 | 20130901 | 0 |